Status:
COMPLETED
International Registry for Intraductal Papillary Mucinous Neoplasma
Lead Sponsor:
Mayo Clinic
Conditions:
Pancreatic Cysts
Eligibility:
All Genders
18-99 years
Brief Summary
A centralized web-based database will be used to track patients with IPMN lesions of the pancreas to study natural history and risk factors for malignant transformation in this multi-center study.
Detailed Description
Intraductal papillary mucinous neoplasms of the pancreas (IPMN) are increasingly recognized in clinical practice. They represent a unique clinicopathologic entity that is characterized by mucin produc...
Eligibility Criteria
Inclusion
- Suspected IPMN based on the consensus guidelines (7)
- Endoscopic ultrasound imaging at baseline examination
- Either surgical histology or clinical follow up with EUS, MRI, or CT scan for at least 1 year
- Cases previously collected that meet the above criteria will be allowed
Exclusion
- Patients who do not meet the above inclusion criteria
Key Trial Info
Start Date :
March 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2019
Estimated Enrollment :
290 Patients enrolled
Trial Details
Trial ID
NCT00828048
Start Date
March 1 2008
End Date
November 1 2019
Last Update
November 6 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic Jacksonville
Jacksonville, Florida, United States, 32224